Pages that link to "Q40622035"

The following pages link to Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines (Q40622035):

Displaying 37 items.

• Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases (Q26775071) (← links)
• Targeting translation initiation in breast cancer (Q27027284) (← links)
• Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy (Q28547787) (← links)
• eEF-2 Phosphorylation Down-Regulates P-Glycoprotein Over-Expression in Rat Brain Microvessel Endothelial Cells (Q28576105) (← links)
• A Ca(2 )-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions (Q28580387) (← links)
• Endocannabinoid-dependent homeostatic regulation of inhibitory synapses by miniature excitatory synaptic activities. (Q30492857) (← links)
• Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway (Q33578980) (← links)
• Prediction and testing of biological networks underlying intestinal cancer (Q33687092) (← links)
• Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer (Q33739303) (← links)
• Eukaryotic elongation factor 2 kinase regulates the development of hypertension through oxidative stress-dependent vascular inflammation (Q33816742) (← links)
• Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library (Q34081089) (← links)
• Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β. (Q34123865) (← links)
• PP2A inhibition overcomes acquired resistance to HER2 targeted therapy (Q34504365) (← links)
• Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K (Q34880928) (← links)
• Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors. (Q35210379) (← links)
• eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. (Q35534450) (← links)
• Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli. (Q36075643) (← links)
• NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression (Q36117536) (← links)
• A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors (Q36183914) (← links)
• MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma (Q36524687) (← links)
• Afferent regulation of chicken auditory brainstem neurons: rapid changes in phosphorylation of elongation factor 2. (Q36576032) (← links)
• Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact (Q36903990) (← links)
• Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress (Q37267450) (← links)
• A critical role of eEF-2K in mediating autophagy in response to multiple cellular stresses (Q37373885) (← links)
• The role of protein synthesis in cell cycling and cancer (Q37442358) (← links)
• The alpha-kinase family: an exceptional branch on the protein kinase tree. (Q37655393) (← links)
• Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma (Q39049380) (← links)
• 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor (Q39454084) (← links)
• Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy (Q39879662) (← links)
• Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells (Q41479561) (← links)
• Reversible covalent inhibition of eEF-2K by carbonitriles. (Q44062393) (← links)
• MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation (Q50962833) (← links)
• Identification of a new isoform of eEF2 whose phosphorylation is required for completion of cell division in sea urchin embryos (Q53282058) (← links)
• 1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features. (Q54976877) (← links)
• Development of a screening strategy for new modulators of T cell receptor signaling and T cell activation. (Q55646587) (← links)
• Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma (Q58694370) (← links)
• Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer (Q89434236) (← links)